Announcements Trials
Browse Landscape

Phase

Phase NA 1

Status

Completed 1

Sponsor Class

OTHER 1

Study Type

Interventional 1

Sponsor

Cancer Type

Breast 1

Conditions

Breast Neoplasms 69Triple Negative Breast Neoplasms 8Carcinoma, Intraductal, Noninfiltrating 6Breast Carcinoma In Situ 4Unilateral Breast Neoplasms 1Transsexualism 1Social Isolation 1Recurrence 1Patient Satisfaction 1Pain, Postoperative 1Neoplasm Micrometastasis 1Margins of Excision 1Lymphedema 1Local Recurrence of Malignant Tumor of Breast 1Inflammatory Breast Neoplasms 1Gynecomastia 1Carcinoma, Ductal, Breast 1Carcinoma, Ductal 1COVID-19 1Breast Image Scale Index for Self Esteem Evaluation 1Breast Cancer Female 1BRCA1/2 Mutation 1Autoimmune Diseases 1Anisomastia 1Anatomic Stage IV Breast Cancer AJCC v8 1Anatomic Stage II Breast Cancer AJCC v8 1Amenorrhea 1

Interventions

abemaciclib 2Radiotherapy 2sargramostim 1ribociclib 1palbociclib 1niraparib 1exemestane 1Mastectomy, Segmental 1Mastectomy 1Letrozole 1Growth and Development 1Fulvestrant 1Everolimus 1Cyclophosphamide 1Continuous Positive Airway Pressure 1Colony-Stimulating Factors 1

Date Range

30 days90 days1 yearAll

Options

Has results Has announcements

Clinical Trials

1 trials
RecentStart dateEnrollment
Unilateral Breast Neoplasms × Mastectomy, Segmental × Breast × Clear all
NCT01496001 2015-10-06

Cosmetic and Functional Outcomes After Breast Conserving Surgery

National Institute of Oncology, Hungary

Phase NA Completed
300 enrolled
Breast

Unilateral Breast Neoplasms, Breast Neoplasms

Data powered by HemOnc (CC BY 4.0) Colophon âš¡